CDKN1C and mantle cell lymphoma: To determine if the observed increase in G1 percentage in MCL cells is due to the restoration of CDKN1C, we knocked down CDKN1C (siRNA) in the presence of erdafitinib; as expected, CDKN1C loss significantly reduced the percent change of G1 cells in response to treatment (Fig. 4I, J).